Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:29
Precision BioSciences Debt to Equity Ratio : 0.5354 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5354 |
| June 30, 2026 | 0.6204 |
| March 31, 2026 | 0.3741 |
| December 31, 2025 | 0.3123 |
| September 30, 2025 | 1.751 |
| June 30, 2025 | 0.8647 |
| March 31, 2025 | 0.603 |
| December 31, 2024 | 0.5328 |
| September 30, 2024 | 0.4672 |
| June 30, 2024 | 0.4123 |
| March 31, 2024 | 0.8346 |
| December 31, 2023 | 1.658 |
| September 30, 2023 | 0.8209 |
| June 30, 2023 | 0.8222 |
| March 31, 2023 | 0.662 |
| December 31, 2022 | 0.413 |
| September 30, 2022 | 0.3254 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.2705 |
| March 31, 2022 | 0.1247 |
| December 31, 2021 | 0.10 |
| September 30, 2021 | 0.1138 |
| June 30, 2021 | 0.1195 |
| March 31, 2021 | 0.171 |
| December 31, 2020 | 0.2368 |
| September 30, 2020 | 0.1718 |
| June 30, 2020 | 0.1276 |
| March 31, 2020 | 0.0974 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 4.842 |
| December 31, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 3.763 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -2.084 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 120.38M |
| Total Liabilities (Quarterly) | 68.60M |
| Shareholders Equity (Quarterly) | 51.78M |
| Current Ratio | 10.47 |
| Net Debt Paydown Yield | 0.20% |